loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2010_164___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Polymed Therapeutics Inc.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 POLYMED THERAPEUTICS, INC. Houston US (1)

    filter

    01 Oxaliplatin (1)

    filter

    01 U.S.A (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    POLYMED THERAPEUTICS, INC. Houston ...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Oxaliplatin

      PDF Supplier PDF
      URL Supplier Web Content
      R1-CEP 2010-164 - Rev 00
      Withdrawn by Holder
      Chemical
      2017-10-17
      2019-06-14
      2017
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2010-164 - Rev 00 of Polymed Therapeutics, Inc. Houston Us

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2010-164 - Rev 00 of Polymed Therapeutics, Inc. Houston Us 1

      20

      Polymed Therapeutics, Inc. Houston Us, based in U.S.A, is a pharmaceutical company.

      One of their significant offerings is Oxaliplatin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2010-164 - Rev 00

      This Chemical Type CEP, issued on October 17, 2017, remains in force until June 14, 2019, ensuring its reliability within the pharmaceutical industry.

      Substance Number 2017 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY